Investors Buy CVS Health (CVS) on Weakness

Investors purchased shares of CVS Health Corp (NYSE:CVS) on weakness during trading hours on Friday. $173.02 million flowed into the stock on the tick-up and $89.54 million flowed out of the stock on the tick-down, for a money net flow of $83.48 million into the stock. Of all equities tracked, CVS Health had the 7th highest net in-flow for the day. CVS Health traded down ($0.24) for the day and closed at $78.78

Several analysts have recently weighed in on the stock. Leerink Swann reiterated an “outperform” rating and set a $85.00 target price (down from $90.00) on shares of CVS Health in a research report on Tuesday, November 7th. Oppenheimer reiterated a “buy” rating and set a $95.00 target price on shares of CVS Health in a research report on Monday, October 9th. Raymond James Financial upgraded shares of CVS Health from an “outperform” rating to a “strong-buy” rating and set a $90.00 target price on the stock in a research report on Thursday, January 4th. They noted that the move was a valuation call. SunTrust Banks set a $85.00 target price on shares of CVS Health and gave the company a “buy” rating in a research report on Thursday, October 12th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of CVS Health in a research report on Thursday, October 12th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $86.66.

The stock has a market capitalization of $79,800.00, a PE ratio of 16.28, a P/E/G ratio of 1.38 and a beta of 0.90. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.64 earnings per share. sell-side analysts expect that CVS Health Corp will post 5.9 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.54%. CVS Health’s dividend payout ratio (DPR) is presently 41.32%.

In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the business’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $75.00, for a total value of $2,208,375.00. Following the transaction, the executive vice president now directly owns 15,556 shares in the company, valued at $1,166,700. The transaction was disclosed in a document filed with the SEC, which is available through this link. 0.61% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Pathstone Family Office LLC raised its stake in shares of CVS Health by 341.0% in the second quarter. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator’s stock worth $2,353,000 after acquiring an additional 982 shares during the last quarter. Wealthcare Advisory Partners LLC raised its stake in shares of CVS Health by 330.3% in the third quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 991 shares during the last quarter. Fieldpoint Private Securities LLC raised its stake in shares of CVS Health by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares during the last quarter. Arcadia Investment Management Corp MI raised its stake in shares of CVS Health by 119.6% in the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after acquiring an additional 726 shares during the last quarter. Finally, MPS Loria Financial Planners LLC bought a new position in shares of CVS Health in the second quarter worth about $119,000. 81.62% of the stock is owned by institutional investors.

WARNING: This news story was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://ledgergazette.com/2018/01/12/investors-buy-cvs-health-cvs-on-weakness.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply